Hemerion Therapeutics is a series a startup based in France. 3 investors tracked.
Hemerion Therapeutics is a startup based in France. Its most recent tracked round is Series A. Brouky records 3 investors associated with the company.
Hemerion Therapeutics develops a unique drug-device combination therapy for glioblastoma, the most aggressive form of brain cancer. The technology integrates a photosensitizing drug with a photonic device to destroy tumor cells during surgery, improving survival and quality of life for patients.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.